The analysis of the IPF-ARGs-TF-miRNA-drug network highlighted three endothelin receptor antagonists targeting EDNRB: Bosentan, Sitaxentan, and Ambrisentan. The gene discussed is EDNRB; the disease is idiopathic pulmonary fibrosis.